Jennifer Ruff
Investor Relations Contact chez DIANTHUS THERAPEUTICS, INC.
Profil
Jennifer Davis Ruff is currently the VP, Head-Investor Relations & Corporate Affairs at Dianthus Therapeutics, Inc. She previously worked as the Director-Investor Relations at Pfizer Inc. from 2007 to 2013, as the VP-Corporate Communications & Investor Relations at Tesaro, Inc. from 2013 to 2018, and as Investor Relations & Corporate Communications at MGI PHARMA Biologics, Inc. from 2003 to 2007.
Jennifer also briefly served as the Vice President-Investor Relations at Pyxis Oncology, Inc. in 2023.
She holds a graduate degree from Northwestern University and an undergraduate degree from the University of Iowa.
Postes actifs de Jennifer Ruff
| Sociétés | Poste | Début |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Investor Relations Contact | 29/11/2023 |
Anciens postes connus de Jennifer Ruff
| Sociétés | Poste | Fin |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Investor Relations Contact | 01/11/2023 |
| TESARO INC | Investor Relations Contact | 01/10/2018 |
| PFIZER, INC. | Investor Relations Contact | 01/03/2013 |
MGI PHARMA Biologics, Inc.
 MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Public Communications Contact | 01/05/2007 |
Formation de Jennifer Ruff
| Northwestern University | Graduate Degree |
| University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
MGI PHARMA Biologics, Inc.
MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Health Technology |
